Latest Breaking News On - Nd b8f de0006046113 - Page 1 : comparemela.com

Biofrontera , an international biopharmaceutical company, announces that the U.S. Food and Drug Administration has added the patent of novel RhodoLED® XL lamp to the FDA Orange Book and further. | March 14, 2022

United statesLudwig lutterBiofrontera pharmaHemmelrather wegEuropean medicines agencyBiofrontera groupDrug administrationFrankfurt stock exchange prime standardOrange bookFrankfurt stock exchangePrime standardLooking statementsPrivate securities litigation reform actBiofrontera ag stock exchangePress releaseNd b8f de0006046113